FDA Adverse Event Injury Summary report: N

FIAPC PROBE 2200 A W/ FILTER

MDR report key: 25299454 · Received May 27, 2026

Report

Report Number
9610614-2026-00092
Event Type
Injury
Date Received
May 27, 2026
Date of Event
April 22, 2026
Report Date
May 27, 2026
Manufacturer
ERBE ELEKTROMEDIZIN GMBH
Product Code
GEI
PMA / PMN Number
K060183
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

THE REUSED SINGLE USE FIAPC PROBE IS IN THE PROCESS OF BEING RETURNED FOR AN EVALUATION (NOTE: THE INSTRUCTIONS FOR USE EXPLICITLY STATE THAT THE PROBE IS INTENDED FOR SINGLE-USE ONLY AND MUST NOT BE REPROCESSED. PROCESSING CAN AFFECT THE MATERIAL PROPERTIES AND/OR FUNCTION OF THE PRODUCT SUCH THAT APPLICATION IN ACCORDANCE WITH THE INTENDED USE IS NO LONGER POSSIBLE. IT ALSO CANNOT BE ENSURED THAT THE PRODUCT WILL BE STERILE AFTER PROCESSING.). IF THE DEVICE IS RETURNED/INSPECTED AND A CONCLUSIVE DETERMINATION IS MADE AS TO THE CAUSE(S) OF THE EVENT, THEN A FOLLOW-UP MDR WILL BE FILED.

Description of Event or Problem · 0

IT WAS REPORTED THAT AN ERBE FIAPC® PROBE WAS INVOLVED IN AN INCIDENT DURING AN ESOPHAGOGASTRODUODENOSCOPY (EGD). NO INFORMATION WAS PROVIDED REGARDING THE APC/ESU SYSTEM USED, OR THE EQUIPMENT SETTINGS EMPLOYED DURING THE PROCEDURE. ALSO, WE ARE UNAWARE OF ANY OTHER ACCESSORIES USED DURING THE EGD. PER THE REPORT, THE FIAPC PROBE WAS ACTIVATED, BUT THERE WAS NO TISSUE EFFECT (NOTE: IT WAS REPORTED THAT THE SINGLE USE DEVICE WAS BEING REUSED). UPON REMOVING THE FIAPC PROBE FROM THE SCOPE, THE USER HELD THE ACTIVATED DEVICE BY THE DISTAL END AND SLIGHTLY SHOOK IT. THEN, AN ELECTRIC CURRENT SUDDENLY FLOWED THROUGH THE USER'S HAND, CAUSING AN ELECTRIC SENSATION. THIS RESULTED IN A SLIGHT BURN ON THE USER'S FINGER. NO TREATMENT OR HOSPITALIZATION WAS REQUIRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
480545 FIAPC PROBE 2200 A W/ FILTER FIAPC PROBE GEI ERBE ELEKTROMEDIZIN GMBH

Patients

Seq Age Sex Outcome Treatment
1 26 YR Female Other